LRA Congratulates Aurinia on Published Results with FDA-Approved Lupkynis™
May 10, 2021
The highly prestigious medical journal The Lancet published the results of Aurinia’s Phase 3 AURORA 1 study testing...
The Lancet
Lupus Research Alliance Encouraged by Lilly Looking at Potential Lupus Drug for COVID-19
April 23, 2020
The Lupus Research Alliance is pleased to share that Eli Lilly and Company entered into an agreement...
Treat-to-Target is Feasible and Beneficial in Lupus
September 19, 2019
Treating patients with lupus until they reach specific health goals can reduce disease flares and prevent organ...